1.89
Stereotaxis Inc Aktie (STXS) Neueste Nachrichten
Stereotaxis (NYSE American: STXS) registers $79.6M unsold securities, adds $42.1M ATM balance - Stock Titan
Stereotaxis (STXS) to Participate in BTIG Hosted Virtual Meeting - GuruFocus
Stereotaxis: Medical Robotics Upside Offsets Cash Burn And Execution Risks (NYSE:STXS) - Seeking Alpha
Stereotaxis Inc. 2025 Annual Report: Robotic Magnetic Navigation Systems, Strategic Partnerships, and Market Overview - Minichart
32.4 million revenue surges over 20 percent with regulatory wins, Stereotaxis asserts - Traders Union
Stereotaxis (STXS) Q4 Earnings: EPS Beats, Revenue Misses - GuruFocus
Stereotaxis Inc (STXS) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Advances ... By GuruFocus - Investing.com Canada
Stereotaxis (STXS) Achieves Regulatory Milestones and Revenue Gr - GuruFocus
Stereotaxis Q4 Earnings Call Highlights - MarketBeat
Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates - Bitget
Stereotaxis earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
Stereotaxis (STXS) Projects Strong Revenue Growth by 2026 - GuruFocus
STXS Q4 Revenue Misses Expectations; Strong Backlog Reported - GuruFocus
Stereotaxis reports 20% revenue growth - The Business Journals
Surgical robotics firm Stereotaxis Q4 revenue jumps - TradingView
Stereotaxis Q4 Earnings Summary & Key Takeaways - Benzinga
Stereotaxis Reports 2025 Full Year Financial Results - GlobeNewswire
Stereotaxis, Inc. schedules Q4 and full year 2025 earnings call for 4:30 PM ET - Traders Union
Aug Weekly: Should I buy Stereotaxis Inc stock nowJuly 2025 Chart Watch & Fast Entry High Yield Tips - baoquankhu1.vn
AI Robot in Heart Treatment Market Is Going to Boom | Major Giants Intuitive Surgical, Stereotaxis, Auris Health - openPR.com
Stereotaxis (STXS) Set to Release Q4 Earnings with Revenue Growt - GuruFocus
Preview: Stereotaxis's Earnings - Benzinga
Stereotaxis Inc. (NYSEAMERICAN:STXS) Short Interest Update - Defense World
Treasury Yields: Should value investors consider Stereotaxis IncTrade Risk Summary & Low Risk Investment Opportunities - baoquankhu1.vn
Robotic technology shields patients and doctors from radiation, Stereotaxis asserts - Traders Union
Short Interest in Stereotaxis Inc. (NYSEAMERICAN:STXS) Increases By 21.2% - MarketBeat
STXSStereotaxis Reports 2022 First Quarter Financial Results - mx.advfn.com
Form S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments - Revista ADVFN
Stereotaxis, Inc. promotes direct experience of RoboticEP benefits through interactive demonstration - Traders Union
Stereotaxis (STXS) Projected to Release Earnings on Monday - MarketBeat
STXS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Can Stereotaxis Inc. keep up with sector leadersJuly 2025 Final Week & Verified Chart Pattern Trade Signals - mfd.ru
Stereotaxis (NYSEAMERICAN:STXS) Shares Up 2.5%Still a Buy? - MarketBeat
Fed Watch: Does Stereotaxis Inc align with a passive investing strategyQuarterly Profit Report & Risk Controlled Stock Alerts - baoquankhu1.vn
Will Stereotaxis Inc. stock recover after earningsMarket Volume Summary & Safe Entry Trade Reports - mfd.ru
Why Stereotaxis Inc. stock is favored by top institutionsQuarterly Performance Summary & Community Consensus Stock Picks - mfd.ru
Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026 - GlobeNewswire
Stereotaxis announces launch of electrophysiology program at Klinikum Furth - Yahoo Finance
Will Stereotaxis Inc. stock benefit from sector rotationJuly 2025 Selloffs & Risk Adjusted Buy and Sell Alerts - mfd.ru
Stereotaxis (STXS) Launches Robotic Electrophysiology Program in Germany - GuruFocus
Klinikum Fürth Establishes Leading Robotic Heart Arrhythmia Program - GlobeNewswire
Trade Recap: What are the risks of holding Stereotaxis IncMarket Activity Report & Accurate Trade Setup Notifications - baoquankhu1.vn
Stereotaxis (NYSEAMERICAN:STXS) Stock Price Down 1.6%Here's What Happened - MarketBeat
Stereotaxis Bets On New Catheters To Turn Its Niche Into Growth - Finimize
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):